Skip to main content

Table 1 Clinical Trials of MLN4924

From: Neddylation: a novel modulator of the tumor microenvironment

  1. CR Complete response, PR Partial Response, SD Stable Disease, NR Not Reported, AML Acute Myelogenous Leukemia, MS Myelodysplastic Syndromes, ALL Acute Lymphoblastic Leukemia, CMML Chronic Myelomonocytic Leukemia, CLL Chronic Lymphocytic Leukemia, MN Myeloproliferative Neoplasm, HL Hodgkin lymphoma, HM Hematologic Malignancies, MM Multiple Myeloma